Glutamatergic substrates of drug addiction and alcoholism - Test2 - elhamkhani - TriplyDB

Glutamatergic substrates of drug addiction and alcoholism

Glutamatergic substrates of drug addiction and alcoholism

http://www.wikidata.org/entity/Q24648924

about

Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior Neuropharmacology of alcohol addiction Modafinil blocks reinstatement of extinguished opiate-seeking in rats: mediation by a glutamate mechanism Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats Glutamatergic targets for new alcohol medications Alcohol dependence and free-choice drinking in mice Glutamate transporter 1: target for the treatment of alcohol dependence The development of acamprosate as a treatment against alcohol relapse A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant Dependence Potential role of N-acetylcysteine in the management of substance use disorders Genetic dissection of acute ethanol responsive gene networks in prefrontal cortex: functional and mechanistic implications Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats Acute effects of modafinil on brain resting state networks in young healthy subjects Mechanisms of metabonomic for a gateway drug: nicotine priming enhances behavioral response to cocaine with modification in energy metabolism and neurotransmitter level The role of cystine-glutamate exchange in nicotine dependence in rats and humans Differential effects of chronic ethanol consumption and withdrawal on homer/glutamate receptor expression in subregions of the accumbens and amygdala of P rats Phosphorylation regulates removal of synaptic N-methyl-D-aspartate receptors after withdrawal from chronic ethanol exposure An association between genetic variation in the glutamatergic system and suicide attempts in alcohol-dependent individuals.Interactive Effects of Ethanol and HIV-1 Proteins on Novelty-Seeking Behaviors and Addiction-Related Gene Expression Pharmacotherapies for Overeating and Obesity.Ethanol-Associated Changes in Glutamate Reward Neurocircuitry: A Minireview of Clinical and Preclinical Genetic Findings.Imbalances in prefrontal cortex CC-Homer1 versus CC-Homer2 expression promote cocaine preference.Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse.NrCAM-regulating neural systems and addiction-related behaviors.Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.Relationship between ethanol's acute locomotor effects and ethanol self-administration in male Long-Evans rats.Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preference Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study The effects of mGluR2/3 activation on acute and repeated amphetamine-induced locomotor activity in differentially reared male rats Advances in genetic studies of substance abuse in China Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives.

P2860

Q22241485-29BD13D6-13D8-44B9-8BC7-D1080D34AAD4 Q22241964-2BADAD86-332A-49DC-B71D-73FA291B6342 Q22251110-91901E30-5F62-475D-88FB-F3A375E4368D Q24608557-BEE9AD2C-A8B0-477D-BE11-D13FFA6DC3C3 Q24625355-996409B7-3D8F-4983-A9D0-9FB3398A54C4 Q24631402-B3F82774-A787-4C66-8996-91792ECC3ED0 Q24658267-BD692228-1880-49E5-B090-737ADA3D7CAD Q26824012-7301EE71-5DD0-4DD1-B6EB-B0A3F679B2B2 Q26824106-02331B04-6CE1-4363-AB44-BD1C4FD66F81 Q26861666-E5B408B1-2178-4454-BEBE-5403CCB6EF95 Q26862199-1713E93E-9C9B-448B-9FE5-D578FB3EED8A Q28068256-BD18B456-EA74-4BE7-BD27-82C07C51BD86 Q28081726-D1928466-01DC-40E6-A0A1-490DF026F23D Q28084494-FA1D3B96-EF2A-42D8-A4A3-4AF93F048481 Q28306130-F71015AA-ECB6-4490-84E8-2D3C5C34FB4D Q28383404-B323A652-802D-426E-87EB-DE7289103EE8 Q28481806-3B51F3AD-C16E-4457-9385-481B674D5349 Q28534885-30C73C2C-33F9-494C-BEF1-87CCAEB1E82D Q28539236-8F420484-E172-431A-8056-6D095FA9A523 Q28566669-2B55FA2B-F9F2-40B2-9F74-37FBAAD68773 Q28571723-3A493D0E-DB3F-4E8F-9D89-F687E9B5B1E7 Q28578374-11C08BD5-69DC-4CEE-B1E5-EF99E66418C0 Q30101002-087442B0-E119-4558-8B16-21B30831065F Q30275882-671DFEC6-A0C7-41A5-9F4E-FB4CF33EE2AB Q30351879-AACEB01A-F8C8-4EE3-B251-45E398877111 Q30367006-3A3243AC-57F3-442D-ADE2-770997C4E0F5 Q30447403-ED65E40C-81D0-4557-BE46-FE2EB3429F01 Q30447847-F1D6F1FB-B310-4E3D-9F82-665E5CA4A31A Q30497841-39204A4D-0B06-4530-AB0F-07A7B22E7B38 Q30525650-3749F884-4F9E-4AFE-9399-AD76022A97D8 Q33536778-3016C5A7-AB21-48FD-81AC-E1936F4493FA Q33622387-78BB7CA4-4AFE-4241-A9BC-B385CE559C60 Q33625744-0DFA94D9-168A-4E0F-8B84-27F4A3A414C1 Q33626978-DD784B1C-4909-413D-AF58-608E047DB415 Q33679951-6314CC97-A577-4581-9596-3DE9A27A0B3A Q33700339-C1502D16-C6FF-4862-8C51-0CE5604F659C Q33744466-6F919989-4AE7-4C82-BCC1-02B2CBA6D788 Q33788180-CB980C5F-1DC8-4420-905F-ACB5ED8B142C Q33819245-A392DF60-9854-47AB-B327-27BAB1CA7DE9 Q33821312-45E308BE-A219-492A-B2BF-033B9314887F

P2860

Glutamatergic substrates of drug addiction and alcoholism

http://www.wikidata.org/entity/Q24648924

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Glutamatergic substrates of drug addiction and alcoholism

@ast

Glutamatergic substrates of drug addiction and alcoholism

@en

Glutamatergic substrates of drug addiction and alcoholism

@nl

type

label

Glutamatergic substrates of drug addiction and alcoholism

@ast

Glutamatergic substrates of drug addiction and alcoholism

@en

Glutamatergic substrates of drug addiction and alcoholism

@nl

prefLabel

Glutamatergic substrates of drug addiction and alcoholism

@ast

Glutamatergic substrates of drug addiction and alcoholism

@en

Glutamatergic substrates of drug addiction and alcoholism

@nl

P1433

Q24648924-8E6F914F-AEDA-4122-A438-374FF3BD4524

P1476

Q24648924-8CEE1DE1-2396-40EB-9B5A-EAF31DA4A743

P2093

Q24648924-1352C23E-815A-48CD-91E3-3F8D6F94BB77

Q24648924-A77BCE3A-A499-4C68-B3BC-FD5390BCBEE2

P2860

Q24648924-001A301E-896F-4E29-8F00-6A421296D9E9

Q24648924-00B36A70-B66E-4AC2-849C-322200FBF91B

Q24648924-00BFC77D-411D-4CE5-9AB5-A8E0302D20A2

Q24648924-00EB9223-5170-42CC-A2CE-472746DA3F1C

Q24648924-01130578-2FE9-4136-A996-BC30EA31B8C1

Q24648924-013B415E-4BD9-440E-82DB-BB3448FA9E4E

Q24648924-01695EEA-E11B-4C8D-8F1A-08BEB4E7B803

Q24648924-01D347D5-D837-4622-9D23-8B5D806BE674

Q24648924-0285B83D-E1EF-4CAE-9DB6-9BF8CC4A1F22

Q24648924-02A09DC3-6B4C-4D8B-AA35-47667C4B8282

P304

Q24648924-FD13FA07-180C-45C7-AEDE-A5C8118B5686

P31

Q24648924-531A3214-8CFB-4636-9CD0-62171FFB5AFF

P3181

Q24648924-AC29CA54-6915-4BF2-99C2-8F117E2DA89A

P356

Q24648924-01A67FCC-5048-43CF-86CA-D66880D3E908

P407

Q24648924-59BF5BC9-F402-4111-AC86-9FF2F8DFB39F

P433

Q24648924-72757B13-B198-4899-901A-999F7E59DDBB

P478

Q24648924-0ECFAD68-D917-4124-BF64-F9738A16C22F

P577

Q24648924-36137536-F4F5-4796-AC48-A1D704DFDA0B

P5875

Q24648924-31577F13-AD3F-4338-BFE1-9E3036C5D396

P698

Q24648924-3683F715-61C7-43E3-B69A-3F2094C0A0E5

P921

Q24648924-08182FD4-ADAA-4F0F-8068-DDBF90DD5A81

Q24648924-75E1D49D-03E5-4A8E-B361-73E210F44FE8

P932

Q24648924-350D677E-4AD1-4D65-AC13-B3E1AEE1A233

P3181

P356

J.BCP.2007.06.039

P1433

Biochemical Pharmacology

P1476

Glutamatergic substrates of drug addiction and alcoholism

@en

P2093

Justin T Gass

http://www.w3.org/2001/XMLSchema#string

M Foster Olive

http://www.w3.org/2001/XMLSchema#string

P2860

NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory

Dopamine neuron systems in the brain: an update

Plasticity in the human central nervous system

A synaptic model of memory: long-term potentiation in the hippocampus

Addiction and the brain: The neurobiology of compulsion and its persistence

Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice

The glutamate receptor ion channels

Homer: a link between neural activity and glutamate receptor function

Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins

P304

218-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3188542

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.BCP.2007.06.039

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6132553

http://www.w3.org/2001/XMLSchema#string

P698

17706608

http://www.w3.org/2001/XMLSchema#string

P921

substance dependence

P932

2239014

http://www.w3.org/2001/XMLSchema#string